About Jiangsu Yahong Meditech Company

Adhering to the value concept of “improving human health and making life more dignified”, the company incorporates environmental, social responsibility and governance (ESG) into the company's development strategy with innovative technology as the core driving force, and continues to build and improve the ESG management system. The company is a global specialty innovative pharmaceutical company focusing on urogenital tumors and other major diseases. It is a leading international pharmaceutical company integrating R&D, production and sales in the field of treatment, providing the best integrated diagnosis and treatment solutions for patients in China and around the world. Main products: Photodynamic therapy products, Hikvision, inhibitors, oral small molecule inhibitors, antibacterial drugs, neratinib maleate tablets, etc.